These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26600329)

  • 21. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug resistant tuberculosis: trends and control.
    Prasad R; Gupta N; Singh M
    Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India.
    Andries A; Isaakidis P; Das M; Khan S; Paryani R; Desai C; Dalal A; Mansoor H; Verma R; Fernandes D; Sotgiu G; Migliori GB; Saranchuk P
    PLoS One; 2013; 8(10):e78313. PubMed ID: 24194919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.
    Van Deun A; Salim MA; Das AP; Bastian I; Portaels F
    Int J Tuberc Lung Dis; 2004 May; 8(5):560-7. PubMed ID: 15137531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
    Kumar P; Kumar P; Balooni V; Singh S
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):434-9. PubMed ID: 25859999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.
    Feja K; McNelley E; Tran CS; Burzynski J; Saiman L
    Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
    Bang D; Lillebaek T; Thomsen VØ; Andersen AB
    Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.
    Nathanson E; Gupta R; Huamani P; Leimane V; Pasechnikov AD; Tupasi TE; Vink K; Jaramillo E; Espinal MA
    Int J Tuberc Lung Dis; 2004 Nov; 8(11):1382-4. PubMed ID: 15581210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, patterns, characteristics and challenges in management of multi-drug resistant tuberulosis cases under DOTS-PLUS.
    Natt NK; Nagpal M; Chawla N; Singh T; Deepika ; Singh H
    Indian J Tuberc; 2014 Jul; 61(3):207-12. PubMed ID: 25241569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
    Roberts-Witteveen A; Reinten T; Christensen A; Sintchenko V; Seale P; Lowbridge C
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):850-6. PubMed ID: 26056113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
    Magee MJ; Blumberg HM; Broz D; Furner SE; Samson L; Singh S; Hershow RC
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
    Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.